Archives
-
FLAG Tag Peptide in FtsH–HflK/C Research
2026-10-07
The FLAG tag Peptide (DYKDDDDK) is a conceptual affinity reagent for studying protein complexes, but the supplied FtsH–HflK/C study does not explicitly identify its affinity tag as FLAG. This overview separates vendor-reported properties from published findings and examines how affinity tagging supports structural biology without establishing that the tag causes the reported membrane-proteostasis mechanism.
-
FeaSion Maps RNA Polymerase II CTD Phosphorylation
2026-10-06
Zhu and colleagues introduce FeaSion, an integrated strategy for connecting RNA polymerase II CTD phosphorylation sites with their interactors, regulators, genomic occupancy, and transcriptional effects. The study expands the known regulatory landscape beyond canonical kinases and phosphatases while showing that individual CTD sites can influence distinct gene-regulatory and chromatin-associated programs.
-
CBD, Orofacial Pain, and Affective Deficits
2026-10-06
A 2026 Brain Research Bulletin study examines how cannabidiol (CBD) acts across peripheral inflammatory, central endocannabinoid, and affective circuits in mouse models of orofacial and chronic inflammatory pain. Its main contribution is linking reduced nociception with changes in CB2- and CB1-associated signaling and serotonin dynamics, while highlighting the limits of translating behavioral findings from mice to clinical pain care.
-
Cy5 TSA in HCC Research: Evidence and Limits
2026-10-05
This overview explains how horseradish peroxidase catalyzed tyramide deposition can support sensitive spatial detection while separating supplier claims from published evidence. It uses miR-3180 research in hepatocellular carcinoma to compare immunohistochemistry, molecular assays, cell models, and xenograft findings, with emphasis on interpretation, limitations, and applicability.
-
Proteinase K: Molecular Biology Uses and Evidence Limits
2026-10-05
Proteinase K is a broad-spectrum serine protease widely associated with protein hydrolysis in molecular biology and DNA preparation. This overview distinguishes supplier claims from peer-reviewed evidence, explains its conceptual relevance to genomic DNA isolation and enzyme contaminant removal, and clarifies why a 2026 Candida albicans extracellular-vesicle study does not directly validate Proteinase K applications.
-
Five Questions About Annexin V/PI Evidence in ESCC
2026-10-04
A source-grounded overview of Annexin V/PI apoptosis interpretation and the evidence linking HOXC9 to AKT/mTOR signaling in esophageal squamous cell carcinoma, including study design, limitations, and applicability boundaries.
-
From PS Signals to Smarter CD38 CAR-T Decisions
2026-10-03
A translational perspective on how phosphatidylserine externalization detection can contextualize CD38 CAR-T cytotoxicity, fratricide, and cell-state changes—while keeping Annexin V readouts within their evidentiary limits.
-
Calpeptin: From EV Assays to Fibrosis Insight
2026-10-02
Explore how Calpeptin, a potent calpain inhibitor, can be used to connect protease activity with extracellular-vesicle release, cell communication, and pulmonary fibrosis research. This evidence-calibrated guide translates a TNBC study into practical assay decisions without overstating cross-disease conclusions.
-
Mdivi-1: From Fission Biology to Translation
2026-10-01
Mdivi-1 offers translational researchers a cell-permeable way to interrogate DRP1-dependent mitochondrial fission, apoptosis, and tissue injury. This article connects mitochondrial dynamics research with chronic intermittent hypoxia, microbiome-linked metabolism, apoptosis assays, and neuroprotection in ischemic retina while defining the controls needed to move from mechanistic observation to credible disease-model evidence.
-
Liproxstatin-1 for Ferroptosis Research
2026-10-01
Liproxstatin-1 is a practical ferroptosis inhibitor for separating lipid-peroxidation-driven death from apoptosis, oxidative injury, and copper-dependent cytotoxicity. This workflow-focused guide covers cell protection assays, GPX4-deficient models, renal injury studies, controls, formulation, and troubleshooting.
-
CIH, Gut Metabolites, and Mitochondrial Apoptosis
2026-09-30
The reference study integrates gut microbiota profiling, GC–MS metabolomics, and pulmonary apoptosis measurements to examine how chronic intermittent hypoxia (CIH) damages mice. Its findings position mitochondrial fission, gut dysbiosis, and altered fatty-acid metabolism within a connected CIH-associated injury pathway, while showing that Mdivi-1 attenuates several pathological changes.
-
From CD38 Structure to Precision Viability
2026-09-30
Structural tuning of CD38 CAR binders changes the biological questions researchers must ask about target-cell killing, fratricide, and T-cell fitness. This thought-leadership article connects those questions to multiplex-compatible 7-AAD viability workflows, showing how membrane-integrity measurements can strengthen translational decisions without overstating what a single assay can prove.
-
Cy5-UTP RNA Labeling: FISH Workflow & Troubleshooting
2026-09-29
Cy5-UTP converts T7 transcription into a direct far-red RNA probe workflow for FISH, RNA localization, and dual-color expression arrays. This guide connects practical probe synthesis with the SARS-CoV-2 nucleocapsid–GADD34 study, showing how spatial RNA measurements can test stress-granule models without overstating what fluorescence alone can prove.
-
Propidium Iodide in PCOS Cell Death Research
2026-09-29
A translational framework for using Propidium iodide to connect AMH–SMAD4 biology with membrane integrity, apoptosis detection, and reproducible granulosa-cell workflows in PCOS research.
-
Placental Exosomal miR-519d-3p in Preeclampsia
2026-09-28
The reference study links placenta-derived exosomal miR-519d-3p with altered T-cell behavior in preeclampsia, showing increased Jurkat T-cell proliferation, reduced apoptosis, and a shift toward a Th17-associated profile. Its combined sequencing, molecular, proliferation, and apoptosis framework provides a useful model for studying immune tolerance at the maternal–placental interface while highlighting the limits of transformed-cell systems.